Pharmaceuticals

Octreotide Market Outlook: Growth and Forecast Highlights 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the octreotide market from 2026–2035 with trusted insights from The Business Research Company

How much is the Octreotide Market valued at in 2026, and what valuation is forecast for 2030?

The octreotide market has experienced consistent expansion in recent years. It is projected to increase from $2.56 billion in 2025 to $2.69 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.0%. The expansion observed historically can be ascribed to several factors, including clinical success in acromegaly treatment, rising diagnosis of neuroendocrine tumors, availability of depot formulations, expansion of endocrine specialty care, and hospital-based hormone therapy adoption.

The octreotide market is projected to experience consistent expansion over the upcoming years, reaching a valuation of $3.26 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.9%. This anticipated growth stems from several factors, including the rising demand for long-acting injectables, a growing incidence of endocrine disorders, broadening oncology indications, an increase in hospital infusion capacity, and advancements in sustained-release formulations. Key trends anticipated during this period involve the increasing application of octreotide in hormonal disorder management, greater adoption of its long-acting injectable forms, its expanded use in treating neuroendocrine tumors, a rising need for hospital-administered therapies, and an enhanced focus on managing symptoms in chronic conditions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21234&type=smp

What Drivers Are Influencing The Growth Of The Octreotide Market?

The rising incidence of cancer is anticipated to drive expansion in the octreotide market in the future. Cancer refers to a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells throughout the body. The escalating prevalence of cancer can be primarily attributed to an aging global populace, environmental influences, specific lifestyle decisions, and advancements in diagnostic techniques. Octreotide contributes to addressing the growing cancer rates through its ability to hinder tumor development, manage cancers linked to hormones, and mitigate accompanying symptoms. To illustrate this point, data released in May 2024 by the National Cancer Institute (NCI), a US-based government agency, indicated almost 20 million new cancer diagnoses and 9.7 million fatalities globally, with forecasts for 2040 projecting an increase to 29.9 million cases and 15.3 million deaths. Consequently, the escalating rates of cancer are serving as a significant impetus for the expansion of the octreotide market.

How Is The Octreotide Market Organized Into Various Segments?

The octreotide market covered in this report is segmented –

1) By Type: Octreotide Acetate, Octreotide, Octreotide Chloride, Octreotide Hydrochloride, Indium In-111 Octreotide

2) By Form: Injection, Powder, Microspheres

3) By Indications: Diarrhea, Acromegaly, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-user: Pharmaceutical, Clinical Research

Subsegments:

1) By Octreotide Acetate: Injectable Formulation, Depot Injectable Formulation

2) By Octreotide: Injectable Formulation, Oral Formulation

3) By Octreotide Chloride: Injectable Formulation, Lyophilized Powder

4) By Octreotide Hydrochloride: Injectable Formulation, Lyophilized Powder

5) By Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation, Therapeutic Radiopharmaceutical Formulation

How Are Emerging Trends Affecting The Progression Of The Octreotide Market?

Leading companies within the octreotide market are prioritizing the development of innovative offerings, such as injectable suspensions, to improve patient adherence and convenience. These injectable suspensions are rapid-acting medications administered through injections, facilitating quicker absorption into the bloodstream and circumventing the digestive system for a faster therapeutic effect. For example, in October 2024, Teva Pharmaceuticals, an Israel-based pharmaceutical company, introduced the generic version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), specifically formulated for rapid bloodstream absorption via injection. Octreotide, a synthetic equivalent of the natural hormone somatostatin, is predominantly utilized for managing conditions like acromegaly, carcinoid syndrome, and VIP-secreting tumors. This injectable delivery method enables a swifter onset of action compared to conventional oral tablets, thereby making it simpler for patients to maintain their treatment protocols.

Who Are The Major Companies Operating In The Octreotide Market?

Major companies operating in the octreotide market are Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, BCN Peptides S.A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/octreotide-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Octreotide Market?

North America was the largest region in the octreotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the octreotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Octreotide Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21234&type=smp

Browse Through More Reports Similar to the Global Octreotide Market 2026, By The Business Research Company

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Octadecanedioic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/octadecanedioic-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795